MeSH tree: F03.900.647
A new study led by researchers at Brown University School of Public Health found that more than half of U.S. jails are located at least a 30-minute drive from the nearest opioid treatment program—a distance that may make ...
Apr 2, 2026
0
8
Researchers at the National Institutes of Health (NIH) have identified a novel, highly potent opioid that shows potential as a therapy for both pain and opioid use disorder. In a study published in Nature, the team observed ...
Apr 1, 2026
0
21
The community-based opioid treatment program Honor's HEROES at UTHealth Houston may significantly improve treatment retention and quality of life for people with opioid-use disorder, even among those facing major barriers ...
Mar 22, 2026
0
11
University of Rhode Island Clinical Professor of Pharmacy Jeffrey Bratberg partnered with Brandeis University and Boston University researchers in a recent study that found that pharmacy-based methadone dispensing models ...
Mar 17, 2026
0
6
In a clinical trial, a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder (OUD) during pregnancy led to higher rates of abstinence from illicit opioids ...
Mar 16, 2026
0
9
Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more likely to stay in treatment. Those on 17 to 24 milligrams averaged 190 days in care compared to ...
Mar 15, 2026
0
13
A nonfatal opioid overdose is often treated as a near miss. But clinically, it is one of the strongest predictors of future harm—and one of the few moments when patients are actively engaged with the health care system. What ...
Mar 11, 2026
0
5
Virginia Tech researchers are advancing a new generation of vaccines designed to block opioids from reaching the brain and triggering their addictive effects, work that could help prevent overdose deaths that now exceed 100,000 ...
Mar 10, 2026
0
11
Opioids such as fentanyl are "indiscriminate killers" that can be misused by people from all walks of life. But where you live may be more influential than previously realized, according to researchers at Rutgers University.
Mar 9, 2026
0
10
State laws that ban insurance prior authorization for buprenorphine—a leading medication for opioid use disorder—may not help more patients stay in treatment for the recommended minimum of 180 days, Weill Cornell Medicine ...
Mar 6, 2026
0
6
